Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch |
Is a |
Product containing estradiol and norethisterone acetate |
false |
Inferred relationship |
Some |
|
|
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Norethisterone acetate |
false |
Inferred relationship |
Some |
|
|
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Estradiol |
false |
Inferred relationship |
Some |
|
|
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Progesterone |
false |
Inferred relationship |
Some |
|
|
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch |
Is a |
Product containing estradiol and norethisterone (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch |
Has manufactured dose form |
forme pharmaceutique pour usage transdermique et/ou cutané |
false |
Inferred relationship |
Some |
|
|
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Norethisterone |
false |
Inferred relationship |
Some |
|
|
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Norethisterone acetate |
false |
Inferred relationship |
Some |
|
|
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch |
Is a |
Product containing estradiol in topical dosage form |
false |
Inferred relationship |
Some |
|
|
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch |
Is a |
Product containing estradiol and norethisterone acetate |
false |
Inferred relationship |
Some |
|
|
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch |
Has manufactured dose form |
Prolonged-release transdermal patch (dose form) |
false |
Inferred relationship |
Some |
|
|
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch |
Has manufactured dose form |
Cutaneous dose form |
false |
Inferred relationship |
Some |
|
|
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch |
Is a |
Estradiol-containing product in transdermal dose form |
false |
Inferred relationship |
Some |
|
|
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|